CARISMA Therapeutics Plunges 27.93% Amid Volatility

On June 11, 2025, CARISMA Therapeutics experienced a significant drop of 27.93% in pre-market trading, marking a notable shift in investor sentiment towards the company.

In recent trading sessions, CARISMA Therapeutics has shown considerable volatility. The company's shares have seen substantial gains in previous sessions, with reports indicating a rise of 84.56% to $0.42 during Tuesday's pre-market session. This upward trend followed a 71.69% increase to $0.39 during the previous pre-market session, building on a 16.97% gain from the day before. The stock's performance has been characterized by significant activity, with a notable 233.0% increase in trading volume on the same day.

The company's recent performance has been driven by a series of positive developments. On the last trading day, the stock price gained 389.42%, rising from $0.227 to $1.11. This surge in stock price reflects growing investor confidence in the company's prospects. The upward trend in CARISMA Therapeutics' stock price is indicative of a broader market interest in the healthcare sector, with the company's innovative therapies and treatments attracting attention from investors.